-
Health todayCancer refines
Distant-stage incidence and cancer mortality trends differ by site across ten US cancers
In US data for 2004-2023, distant-stage incidence rose for breast and prostate cancer and melanoma, while mortality fell.
Peer-reviewed -
Behavioural scienceAlcohol and drug use refines
Liver disease mortality in Germany has plateaued as deaths at ages 65-74 rose
Germany's age-standardised chronic liver disease mortality barely changed from 2011 to 2023, while France, Italy and Spain saw 21-37% falls.
Preprint · not peer-reviewed -
Data, models and systemsValue in health new
Transvalvular pump in infarct-related cardiogenic shock costs €36,083 per QALY in Germany
A lifetime model puts a microaxial flow pump in infarct-related cardiogenic shock at €36,083 per QALY for German statutory insurers.
Peer-reviewed -
Behavioural scienceSocial connection refines
Chronic loneliness over eight years and 20-year dementia risk in older adults
Chronic loneliness over eight years was linked to higher 20-year dementia risk in older adults, but occasional loneliness was not.
Peer-reviewed -
Health todayObesity, diabetes and GLP-1 refines
First-line SGLT2 inhibitors versus metformin and cardiorenal outcomes in type 2 diabetes
In 36,720 matched pairs, starting SGLT2 inhibitors over metformin was associated with lower risk of major cardiovascular events and death.
Peer-reviewed -
Health todayDementia new
Amyloid-targeting therapy eligibility in China narrowed by diagnosis and biomarker access
A meta-analysis estimated 39,825 Chinese adults eligible for amyloid-targeting therapy under current care, against 14.17 million without access constraints.
Peer-reviewed -
Behavioural scienceInfection and pandemics contradicts
Tuberculosis presentations in Ontario rose after 2020 without tracking SARS-CoV-2 activity
Tuberculosis presentations in the Toronto and Hamilton region rose modestly after 2020, but did not follow community SARS-CoV-2 activity.
Preprint · not peer-reviewed -
Health todayDementia refines
Lecanemab in Chinese patients with Alzheimer's disease over 13 months of routine care
Among 122 Chinese patients with Alzheimer's disease treated with lecanemab, 84% held or improved their Clinical Dementia Rating stage at 13 months and two-thirds became amyloid-negative, but those whose amyloid fell most did not clearly improve most in cognition.
Peer-reviewed -
Health todayDementia refines
Cognitive capacity is higher in later-born generations in European and US cohorts
Later-born generations in European and US cohorts followed over 30 years had higher cognitive capacity and more stable memory.
Peer-reviewed -
Tomorrow's worldSlowing ageing itself contradicts
Lifestyle interventions show no clear effect on epigenetic clocks in randomised trials
Eight randomised trials in 1,675 middle-aged and older adults showed no significant effect of lifestyle interventions on DNA methylation clocks.
Peer-reviewed -
Data, models and systemsHealth systems and access new
Medicaid GLP-1 weight-management dispensing fell 85% after four states ended coverage
Weight-management GLP-1 prescriptions in four Medicaid programmes fell 85% in one quarter, with no rise in diabetes-labelled dispensing.
Preprint · not peer-reviewed -
Health todayObesity, diabetes and GLP-1 new
Tirzepatide reduced BMI by 18.5% over 72 weeks in adolescents with obesity
In 160 adolescents with obesity, weekly tirzepatide cut BMI by 18.5% over 72 weeks, against a 0.5% rise with placebo.
Peer-reviewed